Pneumococcal Vaccine Market Industry Share, Growth, Segments and Forecast - 2031
The global pneumococcal vaccine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market includes the increasing efforts to curb pneumonia among children in developed countries. Whereas, in the developing countries, the increasing spending on infrastructure and rising awareness towards vaccines, are the factors, which are expected to fuel the market growth during the forecasted period.Get Free Sample link @ https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market-share
According to the report by Jon Hopkins, in 2019, 5 million children died before reaching the age of 5 years, out of which around 25% of children died due to pneumonia or diarrhoea. The developing countries in Asia and Africa contribute to around 70% of the global death burden of children due to pneumonia. GAVI (the vaccine alliance) is working towards vaccinating these children who are living in emerging economies. For many countries including the UK, Canada, Russia, Norway, Bill Gates and Melinda Gates Foundation had contributed around $1.5 billion towards the program. By the end of 2018, more than 183 million children were given shot of the vaccine against pneumococcal.
Some of the key global market players include Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., and Astellas Pharma Inc. In June 2020, the Serum Institute of India started supplying vaccines for $2 as compared to $3.5 per dose earlier. The company had agreed to provide 10 million doses per year to the countries which are supported by GAVI for the next 10 years.
Full report of Pneumococcal Vaccine Market available @ https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market-share
Market Coverage
Segment Covered-
o By Vaccine Type
o By Distribution Channel
o By Type
o By Age Group
Competitive Landscape - Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., among others
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Pneumococcal Vaccine Market by Segment
o By Vaccine Type
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
o By Distribution Channel
Public
Private
o By Type
Branded
Generic
o By Age Group
Children
Adult
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market-share
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumococcal Vaccine Market Industry Share, Growth, Segments and Forecast - 2031 here
News-ID: 3689203 • Views: …
More Releases from Orion Market Research
Mouth Ulcers Treatment Market Trends, Business Overview, Industry Growth and For …
The global mouth ulcers treatment market is expected to grow at a significant CAGR during the forecast period (2024-2031). The market is expected to be driven by rising awareness about oral hygiene and an increase in the geriatric population. Mouth ulcers are painful sores and bruises that appear in the mouth mucous membrane. Some of the key growth stimulants for the market include the increasing use of synthetics in oral…
Pharmaceuticals for Women's Health Market Emerging Trend, Industry Demand and Re …
The global pharmaceuticals for women's health market is expected to grow at a significant CAGR during the forecast period (2024-2031). The rising occurrence of polycystic syndrome (PCOS) has aided market growth. The development of medicines for the betterment of women's health is supporting the market growth. There is a variety of drugs, surgical options, and preventative measures available for women for a range of disorders. Changes in food choices, stress,…
Phosphate Binders Market Demand Analysis, Type, Statistics, Regions and Forecast …
The global phosphate binders' market is expected to grow at a significant CAGR during the forecast period (2024-2031). Cardiovascular diseases and diabetes lead to common complications such as nephrology and urology disorders. Unhealthy food habits and drugs are known to cause nephrological and urological diseases. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 26 million people have chronic kidney diseases in the US. The…
Photosensitizer Drug Market Revenue, Industry Growing Demand, Top Companies, Reg …
The global photosensitizer drug market is expected to grow at a significant CAGR during the forecast period (2024-2031). In photodynamic therapy (PDT), photosensitizer medications or photosensitizing chemicals are utilized to treat cancer. When these compounds are exposed to a specific wavelength of light, an active form of oxygen is produced, which kills cancer cells nearby. Porphyrin derivatives, Aminolevulinic acid (ALA), chlorines, are some available porphyrin derivatives. Porphyrin derivative (PD), a…
More Releases for Vaccine
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%.
An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the…